Lionhead shares with four consecutive limit-ups: The company's stock trading has abnormal fluctuations, and there are currently no significant matters that should be disclosed but have not been disclosed

According to Jinshi Data on March 13, LIONHEAD announced that the closing price of the company's stock had deviated by more than 20% over two consecutive trading days on March 12 and 13, 2025, which constitutes an abnormal fluctuation in stock trading. After self-examination and written inquiries to the controlling shareholder and actual controller, the company confirmed that there are no significant matters that should be disclosed but have not been disclosed. At the same time, the company is planning to acquire 100% of Hangzhou Lipo Technology Co., Ltd. through the issuance of shares and cash payment, and to raise supporting funds. However, the audit and evaluation of the target assets for this transaction have not yet been completed, the transaction price has not been determined, and the transaction plan must go through necessary internal decision-making procedures and obtain approval from relevant regulatory agencies before it can be implemented, which presents significant uncertainty